Literature DB >> 15557612

Fine mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis.

James G Smedley1, Bruce A McClane.   

Abstract

Clostridium perfringens enterotoxin (CPE) has a unique mechanism of action that results in the formation of large, sodium dodecyl sulfate-resistant complexes involving tight junction proteins; those complexes then induce plasma membrane permeability alterations in host intestinal epithelial cells, leading to cell death and epithelial desquamation. Previous deletion and point mutational studies mapped CPE receptor binding activity to the toxin's extreme C terminus. Those earlier analyses also determined that an N-terminal CPE region between residues D45 and G53 is required for large complex formation and cytotoxicity. To more finely map this N-terminal cytotoxicity region, site-directed mutagenesis was performed with recombinant CPE (rCPE). Alanine-scanning mutagenesis produced one rCPE variant, D48A, that failed to form large complexes or induce cytotoxicity, despite having normal ability to bind and form the small complex. Two saturation variants, D48E and D48N, also had a phenotype resembling that of the D48A variant, indicating that both size and charge are important at CPE residue 48. Another alanine substitution rCPE variant, I51A, was highly attenuated for large complex formation and cytotoxicity, but rCPE saturation variants I51L and I51V displayed a normal large complex formation and cytotoxicity phenotype. Collectively, these mutagenesis results identify a core CPE sequence extending from residues G47 to I51 that directly participates in large complex formation and cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557612      PMCID: PMC529159          DOI: 10.1128/IAI.72.12.6914-6923.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Similar frequency of detection of Clostridium perfringens enterotoxin and Clostridium difficile toxins in patients with antibiotic-associated diarrhea.

Authors:  C Abrahao; R J Carman; H Hahn; O Liesenfeld
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-09       Impact factor: 3.267

Review 2.  Beta-barrel pore-forming toxins: intriguing dimorphic proteins.

Authors:  A P Heuck; R K Tweten; A E Johnson
Journal:  Biochemistry       Date:  2001-08-07       Impact factor: 3.162

3.  Clostridium perfringens type A enterotoxin forms mepacrine-sensitive pores in pure phospholipid bilayers in the absence of putative receptor proteins.

Authors:  S P Hardy; C Ritchie; M C Allen; R H Ashley; P E Granum
Journal:  Biochim Biophys Acta       Date:  2001-11-01

4.  Amino-terminal hydrophobic region of Helicobacter pylori vacuolating cytotoxin (VacA) mediates transmembrane protein dimerization.

Authors:  M S McClain; P Cao; T L Cover
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 5.  Coming to grips with integrin binding to ligands.

Authors:  M Amin Arnaout; Simon L Goodman; Jian-Ping Xiong
Journal:  Curr Opin Cell Biol       Date:  2002-10       Impact factor: 8.382

6.  Crystal structure of staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel.

Authors:  R Olson; H Nariya; K Yokota; Y Kamio; E Gouaux
Journal:  Nat Struct Biol       Date:  1999-02

7.  Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells.

Authors:  U Singh; L L Mitic; E U Wieckowski; J M Anderson; B A McClane
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

8.  CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin.

Authors:  U Singh; C M Van Itallie; L L Mitic; J M Anderson; B A McClane
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

9.  Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis.

Authors:  J F Kokai-Kun; K Benton; E U Wieckowski; B A McClane
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

10.  Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein.

Authors:  K Fujita; J Katahira; Y Horiguchi; N Sonoda; M Furuse; S Tsukita
Journal:  FEBS Lett       Date:  2000-07-07       Impact factor: 4.124

View more
  25 in total

1.  Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity.

Authors:  James G Smedley; Juliann Saputo; Jacquelyn C Parker; Mariano E Fernandez-Miyakawa; Susan L Robertson; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

2.  Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin.

Authors:  Susan L Robertson; James G Smedley; Bruce A McClane
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

3.  Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins.

Authors:  Kengo Kitadokoro; Kousuke Nishimura; Shigeki Kamitani; Aya Fukui-Miyazaki; Hirono Toshima; Hiroyuki Abe; Yoichi Kamata; Yoshiko Sugita-Konishi; Shigeki Yamamoto; Hajime Karatani; Yasuhiko Horiguchi
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

Review 4.  Animal models to study the pathogenesis of enterotoxigenic Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane
Journal:  Microbes Infect       Date:  2012-06-17       Impact factor: 2.700

5.  Inhibition of the Protein Phosphatase CppA Alters Development of Chlamydia trachomatis.

Authors:  Ja E Claywell; Lea M Matschke; Kyle N Plunkett; Derek J Fisher
Journal:  J Bacteriol       Date:  2018-09-10       Impact factor: 3.490

6.  Potential Therapeutic Effects of Mepacrine against Clostridium perfringens Enterotoxin in a Mouse Model of Enterotoxemia.

Authors:  Mauricio A Navarro; Archana Shrestha; John C Freedman; Juliann Beingesser; Bruce A McClane; Francisco A Uzal
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

7.  Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation.

Authors:  Jianwu Chen; James R Theoret; Archana Shrestha; James G Smedley; Bruce A McClane
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

Review 8.  The interaction of Clostridium perfringens enterotoxin with receptor claudins.

Authors:  Archana Shrestha; Francisco A Uzal; Bruce A McClane
Journal:  Anaerobe       Date:  2016-04-16       Impact factor: 3.331

9.  A wide variety of Clostridium perfringens type A food-borne isolates that carry a chromosomal cpe gene belong to one multilocus sequence typing cluster.

Authors:  Yinghua Xiao; Arjen Wagendorp; Roy Moezelaar; Tjakko Abee; Marjon H J Wells-Bennik
Journal:  Appl Environ Microbiol       Date:  2012-08-03       Impact factor: 4.792

Review 10.  Toxin plasmids of Clostridium perfringens.

Authors:  Jihong Li; Vicki Adams; Trudi L Bannam; Kazuaki Miyamoto; Jorge P Garcia; Francisco A Uzal; Julian I Rood; Bruce A McClane
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.